These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2895719)

  • 1. Somatostatin release from dispersed hypothalamic cells: effects of diabetes.
    Richardson SB; Twente S
    Diabetologia; 1987 Nov; 30(11):893-8. PubMed ID: 2895719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
    Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M
    Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of diabetes on in vivo and in vitro hypothalamic somatostatin release.
    Joanny P; Peyre G; Steinberg J; Guillaume V; Pesce G; Becquet D; Oliver C
    Neuroendocrinology; 1992 May; 55(5):485-91. PubMed ID: 1350065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired suppression of growth hormone release by somatostatin in cultured adenohypophyseal cells of spontaneously diabetic BB/W rats.
    Welsh JB; Szabo M
    Endocrinology; 1988 Nov; 123(5):2230-4. PubMed ID: 2901949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered release of growth hormone from dispersed adenohypophysial cells of streptozotocin diabetic rats. I. Effects of growth hormone releasing factor and somatostatin.
    Sheppard MS; Eatock BA; Bala RM
    Can J Physiol Pharmacol; 1989 Oct; 67(10):1315-20. PubMed ID: 2575447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time course of hypothalamic growth hormone-releasing hormone and somatostatin content in streptozocin diabetic rats: evidence for early changes in hypothalamic regulation.
    Leidy JW; Cugini CD; Driscoll HK; Chertow BS
    Brain Res; 1995 May; 681(1-2):84-90. PubMed ID: 7552296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic secretion of somatostatin and growth hormone-releasing factor into the hypophysial-portal circulation is reduced in streptozotocin diabetic male rats.
    Plotsky PM
    Neuroendocrinology; 1991 May; 53(5):433-8. PubMed ID: 1678493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in somatostatin concentration in pancreas and other tissues of streptozotocin diabetic rats.
    Patel YC; Cameron DP; Bankier A; Malaisse-Lagae F; Ravazzola M; Studer P; Orci L
    Endocrinology; 1978 Sep; 103(3):917-23. PubMed ID: 154402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered release of growth hormone from dispersed adenohypophysial cells of streptozotocin diabetic rats. II. Effects of a phorbol ester and secretagogues which increase cyclic AMP.
    Sheppard MS; Eatock BA; Bala RM
    Can J Physiol Pharmacol; 1989 Oct; 67(10):1321-5. PubMed ID: 2482123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic regulation of impaired growth hormone secretion in diabetic rats. 1. Studies in streptozotocin-induced diabetic rats.
    Ndon JA; Giustina A; Wehrenberg WB
    Neuroendocrinology; 1992 May; 55(5):500-5. PubMed ID: 1350066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon, insulin and somatostatin secretion in response to sympathetic neural activation in streptozotocin-induced diabetic rats. A study with the isolated perfused rat pancreas in vitro.
    Kurose T; Tsuda K; Ishida H; Tsuji K; Okamoto Y; Tsuura Y; Kato S; Usami M; Imura H; Seino Y
    Diabetologia; 1992 Nov; 35(11):1035-41. PubMed ID: 1361917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between growth hormone-releasing hormone and somatostatin in the rat: effects of age and sex on content and in-vitro release from hypothalamic explants.
    Ge F; Tsagarakis S; Rees LH; Besser GM; Grossman A
    J Endocrinol; 1989 Oct; 123(1):53-8. PubMed ID: 2572665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal D cell secretion in alloxan-diabetes: influence by drug and aberrant metabolism.
    Grill V; Efendić S
    Am J Physiol; 1984 Jun; 246(6 Pt 1):E483-92. PubMed ID: 6204535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression analysis of hypothalamic and pituitary components of the growth hormone axis in fasted and streptozotocin-treated neuropeptide Y (NPY)-intact (NPY+/+) and NPY-knockout (NPY-/-) mice.
    Park S; Peng XD; Frohman LA; Kineman RD
    Neuroendocrinology; 2005; 81(6):360-71. PubMed ID: 16244497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide-Y concentration in microdissected hypothalamic regions and in vitro release from the medial basal hypothalamus-preoptic area of streptozotocin-diabetic rats with and without insulin substitution therapy.
    Sahu A; Sninsky CA; Kalra PS; Kalra SP
    Endocrinology; 1990 Jan; 126(1):192-8. PubMed ID: 2136723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroidectomy abolishes pulsatile growth hormone secretion without affecting hypothalamic somatostatin.
    Martin D; Epelbaum J; Bluet-Pajot MT; Prelot M; Kordon C; Durand D
    Neuroendocrinology; 1985 Dec; 41(6):476-81. PubMed ID: 2867482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dopamine and morphine on immunoreactive somatostatin and LH-releasing hormone secretion from hypothalamic fragments in vitro.
    Lengyel AM; Grossman A; Bouloux PM; Rees LH; Besser GM
    J Endocrinol; 1985 Sep; 106(3):317-22. PubMed ID: 2864381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal relationship of tissue somatostatin-like immunoreactivity to metabolic changes in genetically obese and diabetic mice.
    Berelowitz M; Coleman DL; Frohman LA
    Diabetes; 1980 Sep; 29(9):717-23. PubMed ID: 6108273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of the abnormal pancreatic D and A cell function in streptozotocin diabetic dogs: studies with D-glyceraldehyde, dihydroxyacetone, D-mannoheptulose, D-glucose, and L-arginine.
    Hermansen K
    Diabetologia; 1981 Nov; 21(5):489-94. PubMed ID: 6117495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of acute and chronic administration of clonidine on hypothalamic content of growth hormone-releasing hormone and somatostatin in the rat.
    Gil-Ad I; Laron Z; Koch Y
    J Endocrinol; 1991 Dec; 131(3):381-5. PubMed ID: 1686052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.